Using Blinatumomab in Acute Lymphoblastic Leukemia
0 Bekeken
• 06/15/23
0
0
insluiten
administrator
abonnees
The discussants, Bijal D. Shah, MD, and Raoul Tibes, MD, PhD, elaborate on the administration and safety of bi-specific T-cell engager, blinatumomab, in the treatment of acute lymphoblastic leukemia.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties